Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ISRCTN75963665) titled 'Phase I Study (QSC303441)' on Dec. 23, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
Purpose: Phase 1 study in healthy volunteers
Primary Sponsor: Novartis Pharmaceuticals UK Ltd.
Condition:
Healthy volunteers
Other
Intervention:
The sponsor has confirmed that the trial meets the criteria for d...